pfizer inverse Head & Shoulders inverse Head and shoulders pattern on weekly frame and rejected from 200 EMA , great entry point or enter after confirmed breakout .
PFE trade ideas
$PFE Prizer Inc $44.00 Target
PFE stock hitting yearly candle resistance @$41.00 pre market, a break above will
open the potential for a move to $42.00 & $44.00.
Stock is overbought so look after profits
PFIZER D1The UK is the first country in the world to approve a coronavirus vaccine from Pfizer and BioNTech. The vaccine will be available nationwide from December 7th. The authorities have already ordered 40 million doses of the drug. Since for the vaccine to be effective, patients need to be given two injections, the drug will last for 20 million people, The Guardian notes.
The first to receive the vaccine will be Britons with an increased risk of infection - first residents and staff of nursing homes, then other citizens over 80 years old and then healthcare workers. Mass vaccination for people over 50, as well as young citizens with chronic diseases, will become possible with the receipt of more doses of the drug in 2021.
Pfizer and BioNTech also filed applications for their vaccine on November 20 with the US Food and Drug Administration and on November 30 with the European Medicines Agency. If the approval of the American regulator is received, the use of the drug in Europe could begin as early as December. The cost of one dose of the vaccine for EU countries will be 15.5 ($ 18.34) euros, Reuters previously reported.
According to the test results, Pfizer and BioNTech estimated the effectiveness of their vaccine at 95%. Of the 170 volunteers who tested the drug and contracted the coronavirus, 162 received a placebo and only 8 were vaccinated with the candidate vaccine.
PFE Long term Bull Prediction Split.PFE will do great long term, just the way it will go in the shorter term is a question. #2 kinda seems more likely if PFE gets proper FDA approval and no hiccups. #1 is for the hiccups and if other vaccines do better.
PFE Long, Strong Buy$PFE (Pfizer) stock price will skyrocket once UK and US approve the medicine for the COVID-19 vaccine.
PFEWith Pfizer being one of the current leaders in the Covid vaccine race, the European Medicines Agency is projected to approve the vaccine within the next month. Potential for a major push from PFE these upcoming weeks when announced. If it is able to break above the 37.20 line, expect trend to go upwards.
Pfizer heading upWith their vaccine about to be released and with the technicals showing it being squeezed higher and higher, the lows are making new highs, potential price target 40$ then higher depending on news. Only up
PFE Ascending Triangle LongNYSE:PFE looks like it's currently in an Ascending Triangle, which could possibly break out once it hits support at the low trend line. I predict it could reach 42, although would recommend selling before that.
WARNING: I am not a stock expert and am just learning technicals and chart patterns, if you like this idea and would like to replicate it please use fake money to test out this strategy.
pfizer stock analysisThe idea is to go long - just wait the possible end of the price retracement
NYSE:PFE
PFE - Elliottwave analysis - ABC zigzag down PFE - It has completed A wave down and correcting higher in B wave. Sell it near 37.50- 38.50 with invalidation level above 39.76 for target zone below 33 level.
Give thumbs up if you really like the trade idea.
symmetrical triangle, higher lows, decreasing volumebouncing off middle channel (orange line), higher lows, decreasing volume.
with covid-19 vaccine shenanigans, we may test all time highs again.
PFE LongWeekly Chart for long term
Downtrend Channel breakout + retest
Uptrend trendline as support
Entry 37
Stop 34.5
target: 44;
I am not a PRO trader. I need few months to practice trading strategies.
If you like this idea, please use SIM/Demo account to try it, until my trading plans get high winning rate.
Pfizer inc. LONG📈 NYSE:PFE LONG H4
🛒BUY above = 40.05
🎯Target1 = 45.74
🎯Target2 = 48.05
🎯Target3 = 51.74
🛑Trailing Stop loss = 36
❌Cancel trade and open reverse trade = 36
🙈Recommended risk = 3-5%
#PFE #PFELONG #BUYPFE
Pfizer again, plus some Boeing and BrexitAfter the US elections, the focus of the markets shifted to the pandemic and news from the world of vaccines. So the news of the day again was the information about the final results of the COVID-19 vaccine trial from Pfizer Inc.
Recall, according to preliminary data, the effectiveness of the vaccine was 90%. Since then, Moderna has announced that their vaccine is 94.5% effective. But according to the final results from Pfizer, the effectiveness of their vaccine is 95%.
Most importantly, since testing is complete, Pfizer is about to apply for a US emergency acceptance. According to Pfizer, the vaccine committee meeting will take place in December. That is, about a month remains to wait until an officially approved and effective vaccine appears on the shelves.
But do not forget that it will be months (rather quarters), before its widespread use begins and a turning point in the pandemic takes place.
US regulators intend to allow the Boeing 737 MAX to fly again after a nearly two-year pause. As a reminder, this aircraft was Boeing's most financially successful until two fatal crashes in 2018 and 2019. But given the scale of the crisis in the airline industry and its rather bleak prospects, the news failed to trigger a steady rise in Boeing's stock.
Note that just a few days ago Bill Gates said that according to his forecasts, after the pandemic, the number of business trips will decrease by more than 50%. Before the pandemic, it was business travel that accounted for half (!) of US airlines' revenues.
It is reported that France has agreed that its fishing rights in UK waters will be limited after the end of the transition period on 31 December. Note what exactly is one of the most serious obstacles on the way to a Brexit deal.
PFIZER LONGThey are making like 200 million vaccines. They are at a supply zone. Honestly, it will prob just continue going sideways but there are so upper targets there. Good dividend. Sell at 33 or 30.
